International Women’s Day 2023
Today we are proud to celebrate and recognize the remarkable contributions of women and girls everywhere. Many women are still facing significant barriers due to gender bias and we believe …
Blog
Open Position: Bioinformatician [Aniling202301]
Aniling is hiring a bioinformatician to join our team! Interested applicants should send the following documents to info@aniling.com: – A short statement of motivation – A CV including your contact …
World Cancer Day 2023
In 2 days, we will mark World Cancer Day. World Cancer Day is a global uniting initiative led by the Union for International Cancer Control (UICC). It aims to promote awareness …
Retos Colaboration 2017 project completion
Aniling completes the Retos Colaboración project with the development of a genetic and epigenetic test (GEUS-LB®) for the early detection of colorectal cancer in a blood sample. The Aniling -led project uses patented GEUS …
CARE, the new Translational Program in Cancer Research promoted by the IGTP
Miguel A. Peinado, CSO at Aniling, is Co-Director of CARE, the new Translational Program in Cancer Research promoted by the IGTP, which was presented last month in the Hospital Universitari Germans Trias …
Aniling in the ERIC International Meeting 2022
This week Aniling is attending the ERIC | European Research Initiative on CLL International Meeting in Barcelona focused on Chronic Lymphocytic Leukemia (CLL) as a paradigmatic disease for realizing the concepts of precision medicine towards improving …
Farmabiotec reports Aniling achievements
The health biotechnology magazine Farmabiotec reports on Aniling’s late achivements. Farmabiotec goes through Aniling’s IVD tests for chronic lymphocytic leukaemia, colorectal cancer and liquid biopsy and highlights their recent CE …
World CLL Day 2022
Every 1 September, the global CLL community unites to raise awareness about chronic lymphocytic leukemia (CLL) and give those affected by a diagnosis of CLL a much needed voice. On …
Aniling obtains European certification for diagnostic tests for chronic lymphocytic leukaemia, colorectal cancer and liquid biopsy
Aniling has obtained CE certification for its first in vitro diagnostic (IVD) tests for chronic lymphocytic leukaemia, colorectal cancer and liquid biopsy. Aniling has successfully complied with the requirements established …
Expansion reports Aniling achievements
Expansión newspaper explains the company’s latest milestone: Aniling obtains CE marking for three in vitro tests for chronic lymphocytic leukaemia, colorectal cancer and liquid biopsy. News written by Gabriel Trindade …